Analytical Data
-
基因名
Dsg1a
- Application
-
别名
DG1 (DGI) (Desmosomal glycoprotein I) (Desmoglein-1) (Dsg1-alpha) (Dsg1)
-
种属
Mouse
-
表达系统
E. coli
-
标签
N- His-SUMO & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q61495
-
表达区间
50-564aa
-
分子量
77.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Dsg1a (Desmoglein 1a) is a critical member of the desmosome protein family, which plays a vital role in maintaining cell adhesion and epidermal integrity in human skin. Mutations or dysregulation of Dsg1a are associated with various skin disorders, such as pemphigus foliaceus and other autoimmune diseases. The recombinant production of Dsg1a has garnered significant interest in recent years, as it provides an opportunity to study its structure, function, and interactions with other cellular components in vitro. Researchers aim to understand the molecular mechanisms underlying desmosomal adhesion and the pathogenesis of related diseases by generating Dsg1a in a recombinant system. The purified protein can be used for biochemical assays, structural determination, and the development of therapeutic strategies. Moreover, producing Dsg1a in a heterologous expression system can facilitate the investigation of protein folding, post-translational modifications, and potential functional assays, advancing our understanding of its role in epidermal cell biology and disease. As the field evolves, the focus is also shifting towards potential applications in regenerative medicine and targeted therapies that leverage the unique properties of desmosome proteins, highlighting the importance of Dsg1a research in both basic and translational science.












